Insider · CIK 0001238705

BENDER LEWIS H

Reports to the SEC for 3 companies · SHELTON, CT

sec.gov

Transactions

Companies

Filings

CIK

0001238705

Forms 4 and 5

Insider transactions

19 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-16	INTSINTENSITY THERAPEUTICS, INC. · Stock Option (right to buy Common Stock)A Award	Director, President and CEO	AAward	+78K sh	—	—	78,000
2026-03-26	INTSINTENSITY THERAPEUTICS, INC.A Award	Director, President and CEO	AAward	+37.7K sh	$6.11	+$231K	118,549
2025-05-02	INTSINTENSITY THERAPEUTICS, INC. · Stock Option (right to buy Common Stock)A Award	Director, President and CEO	AAward	+700K sh	—	—	700,000
2024-03-06	INTSINTENSITY THERAPEUTICS, INC. · Stock Option (right to buy Common Stock)A Award	Director, President and CEO	AAward	+33.6K sh	—	—	33,574
2024-03-06	INTSINTENSITY THERAPEUTICS, INC. · Stock Option (right to buy Common Stock)A Award	Director, President and CEO	AAward	+465K sh	—	—	464,805
2011-02-14	INTERLEUKIN GENETICS INCStock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+500K sh	—	—	500,000
2010-01-21	INTERLEUKIN GENETICS INCEmployee Stock OptionA Award	Director, Chief Executive Officer	AAward	+100K sh	—	—	100,000
2009-03-13	INTERLEUKIN GENETICS INCA Award	Director, Chief Executive Officer	AAward	+110K sh	$0.27	+$29.7K	201,136
2008-11-20	INTERLEUKIN GENETICS INCP Purchase	Director, Chief Executive Officer	PPurchase	+8,235 sh	$0.32	+$2,635.2	37,081
2008-11-20	INTERLEUKIN GENETICS INCP Purchase	Director, Chief Executive Officer	PPurchase	+1,700 sh	$0.35	+$595	40,546
2008-11-20	INTERLEUKIN GENETICS INCP Purchase	Director, Chief Executive Officer	PPurchase	+1,765 sh	$0.33	+$582.45	38,846
2008-11-18	INTERLEUKIN GENETICS INCP Purchase	Director, Chief Executive Officer	PPurchase	+10K sh	$0.50	+$4,980	28,846
2008-11-18	INTERLEUKIN GENETICS INCP Purchase	Director, Chief Executive Officer	PPurchase	+100 sh	$0.41	+$41	10,646
2008-11-18	INTERLEUKIN GENETICS INCP Purchase	Director, Chief Executive Officer	PPurchase	+8,200 sh	$0.42	+$3,444	18,846
2007-06-07	EMISPHERE TECHNOLOGIES INCStock Option (Right to Buy)A Award	Chief Technology Officer	AAward	+50K sh	$4.17	+$209K	50,000
2005-04-20	EMISPHERE TECHNOLOGIES INCM Exercise/Conversion	Chief Technology Officer	MExercise/Conversion	+317 sh	$2.63	+$833.71	16,387
2005-04-20	EMISPHERE TECHNOLOGIES INCStock Option (Right to Buy)M Exercise/Conversion	Chief Technology Officer	MExercise/Conversion	−317 sh	—	—	0
2005-04-20	EMISPHERE TECHNOLOGIES INCStock Option (Right to Buy)M Exercise/Conversion	Chief Technology Officer	MExercise/Conversion	−7,000 sh	—	—	0
2005-04-20	EMISPHERE TECHNOLOGIES INCM Exercise/Conversion	Chief Technology Officer	MExercise/Conversion	+7,000 sh	$1.50	+$10.5K	23,387

Recent filings

Accepted (ET)
Jul 204
BENDER LEWIS H0001238705-26-000007
SEC(opens sec.gov)
Mar 304
BENDER LEWIS H0001238705-26-000005
SEC(opens sec.gov)
May 64
BENDER LEWIS H0001567264-25-000028
SEC(opens sec.gov)
Mar 74
BENDER LEWIS H0001213900-24-020830
SEC(opens sec.gov)
Feb 164
BENDER LEWIS H0001144204-11-009347
SEC(opens sec.gov)
Jan 224
BENDER LEWIS H0001179110-10-001390
SEC(opens sec.gov)
Mar 164
BENDER LEWIS H0001104659-09-018016
SEC(opens sec.gov)
Nov 204
BENDER LEWIS H0001104659-08-072163
SEC(opens sec.gov)
Aug 134
EMISPHERE TECHNOLOGIES INC0001230295-07-000542
SEC(opens sec.gov)
Apr 224
EMISPHERE TECHNOLOGIES INC0001230295-05-000060
SEC(opens sec.gov)

Companies

Address

C/O INTENSITY THERAPEUTICS, INC. 1 ENTERPRISE DRIVE, SUITE 430

SHELTON, CT, 06484